- Home
- BR vs BNTX Comparison
BR vs BNTX Comparison
Compare BR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BR
- BNTX
- Stock Information
- Founded
- BR 1962
- BNTX 2008
- Country
- BR United States
- BNTX Germany
- Employees
- BR N/A
- BNTX N/A
- Industry
- BR Business Services
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BR Consumer Discretionary
- BNTX Health Care
- Exchange
- BR Nasdaq
- BNTX Nasdaq
- Market Cap
- BR 27.6B
- BNTX 23.9B
- IPO Year
- BR 2007
- BNTX 2019
- Fundamental
- Price
- BR $227.34
- BNTX $114.13
- Analyst Decision
- BR Hold
- BNTX Strong Buy
- Analyst Count
- BR 8
- BNTX 15
- Target Price
- BR $226.71
- BNTX $143.50
- AVG Volume (30 Days)
- BR 448.0K
- BNTX 659.5K
- Earning Date
- BR 01-30-2025
- BNTX 11-04-2024
- Dividend Yield
- BR 1.55%
- BNTX N/A
- EPS Growth
- BR 2.64
- BNTX N/A
- EPS
- BR 5.79
- BNTX N/A
- Revenue
- BR $6,498,600,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- BR $9.50
- BNTX N/A
- Revenue Next Year
- BR $5.42
- BNTX N/A
- P/E Ratio
- BR $39.28
- BNTX N/A
- Revenue Growth
- BR 4.67
- BNTX N/A
- 52 Week Low
- BR $188.30
- BNTX $76.53
- 52 Week High
- BR $237.96
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- BR 47.29
- BNTX 49.15
- Support Level
- BR $222.57
- BNTX $109.52
- Resistance Level
- BR $228.09
- BNTX $115.34
- Average True Range (ATR)
- BR 3.82
- BNTX 4.74
- MACD
- BR -1.51
- BNTX -0.80
- Stochastic Oscillator
- BR 30.99
- BNTX 29.03
About BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communications and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two segments: investor communication solutions and global technology and operations.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.